the effects of age and chronic dosing on the pharmacokinetics of the anti-inflammatory drug etodolac were evaluated in healthy young subjects , healthy elderly subjects , and elderly patients with osteoarthritis .
C0059865
etodolac
C0029408
osteoarthritis